EUVIMEDEUVIMED entdecken
Leserbrief

Aspirin in “Compensated” Cirrhosis: Does the Evidence Concern First or Recurrent Decompensation?

Liverinto-Panagiotis Mela iD, Sofia Spirakou iD, Melina Mela iD

Journal of Gastroenterology and Hepatology · 04.11.2026

DOI: 10.1111/jgh.70867 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 04.11.2026. Verfasst von Liverinto-Panagiotis Mela und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, General Hospital of Chalkida, Chalkida, Greece. Die Arbeit nennt 3 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Internal Medicine, General Hospital of Chalkida, Chalkida, Greece.
  • School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

ORCID-Profile: Liverinto-Panagiotis Mela, Sofia Spirakou, Melina Mela

Zitieren

APA

Mela, L. P., Spirakou, S., & Mela, M. (2026). Aspirin in “Compensated” Cirrhosis: Does the Evidence Concern First or Recurrent Decompensation?. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70867

Vancouver

Mela LP, Spirakou S, Mela M. Aspirin in “Compensated” Cirrhosis: Does the Evidence Concern First or Recurrent Decompensation?. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70867

BibTeX
@article{Mela2026,
  author = {Mela, Liverinto-Panagiotis and Spirakou, Sofia and Mela, Melina},
  title = {Aspirin in “Compensated” Cirrhosis: Does the Evidence Concern First or Recurrent Decompensation?},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1111/jgh.70867}
}
Kostenlos starten →